Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PREDESA

Financiado

Cerrado

Non invasive technology for remote screening and personalised therapy of sleepin...

Non invasive technology for remote screening and personalised therapy of sleeping disorders EU piloting and commercialisation project Sleep apnea (SA) is not just a disease anymore, it is an epidemic affecting more than 500 million people globally. The number of SA patients is increasing rapidly, causing cardiovascular diseases, neurocognitive dysfunction, dayti... ver más

31/01/2020

Nukute

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

NUKUTE OY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-01-31

SMEInst-01-2016-2017: Open Disruptive Innovation Scheme

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Nukute

1.75M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

DESARROLLO DE UN NUEVO TIPO DE DISPOSITIVO MÉ... DESARROLLO DE UN NUEVO TIPO DE DISPOSITIVO MÉDICO CPAP PAR... 465K€ Cerrado

SUNRISE Tx EIisa –a connected, affordable light solution for treating s... 3M€ Cerrado

RTC-2015-3446-1 Nuevos paradigmas no hospitalarios para la simplificación de... 50K€ Cerrado

NEUROON-MED NEUROON MED the future of at home diagnosis of sleep disor... 2M€ Cerrado

RYC2019-027831-I Precision Medicine in Sleep Apnea 309K€ Cerrado

RTC-2014-3138-1 GESTION Y TRATAMIENTO DE PACIENTES CON SINDROME DE APNEAS-HI... 46K€ Cerrado

Duración del proyecto: 27 meses Fecha Inicio: 2017-10-31
Fecha Fin: 2020-01-31

Líder del proyecto

NUKUTE OY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Sleep apnea (SA) is not just a disease anymore, it is an epidemic affecting more than 500 million people globally. The number of SA patients is increasing rapidly, causing cardiovascular diseases, neurocognitive dysfunction, daytime sleepiness, motor vehicle accidents, etc. SA is treatable, but the screening and care is not accessible for most people. Still, over 80% of SA-suffering patients are undiagnosed. Currently, most of the SA diagnostics and therapy is based on complex and stationary technology, available only at clinical settings. Also, the current prevailing methods are invasive, expensive and unreliable. Waiting lists are long, nearly 40% of performed analysis fail and when once diagnosed, patients tend to ditch the treatment soon. Nukute has a solution. We introduce a telemedicine ready technology that exceeds the current state-of-the-art technologies in analysis reliability, cost, therapy functions and user comfort. It is an excellent addition to expensive, stationary and error-prone polysomnography analysis and enables to extend SA screening service to wider patients´ audiences for 90% lower cost. Our technology combines sensitive microphones and gravity-meters with advanced diagnostics software to identify and predict upcoming SA events. Our unique collar device can diagnose different types of sleep apnea by monitoring the patient´s breathing quality and the respiratory rate and profile. The integrated Therapy function is based on body conditioning. It sends small electric pulses to stimulate the throat muscles when apnea or snoring occurs, without waking up the patient. The HW is integrated with applications running on a smartphone, tablet or laptop. The technology is already tested successfully against clinical equipment in Finnish hospitals. As a direct result of the project, Nukute will finalise the technology, ensure market clearance in EU and USA and are ready to start market introduction with Screening device from 2018.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores